Literature DB >> 30058469

It is time to conduct phase 3 clinical trials of sex hormones in MS - Yes.

Rhonda Voskuhl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30058469      PMCID： PMC6173646          DOI： 10.1177/1352458518768764

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  13 in total

1.  Policy: NIH to balance sex in cell and animal studies.

Authors:  Janine A Clayton; Francis S Collins
Journal:  Nature       Date:  2014-05-15       Impact factor: 49.962

Review 2.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

3.  Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

Authors:  Rhonda R Voskuhl; HeJing Wang; T C Jackson Wu; Nancy L Sicotte; Kunio Nakamura; Florian Kurth; Noriko Itoh; Jenny Bardens; Jacqueline T Bernard; John R Corboy; Anne H Cross; Suhayl Dhib-Jalbut; Corey C Ford; Elliot M Frohman; Barbara Giesser; Dina Jacobs; Lloyd H Kasper; Sharon Lynch; Gareth Parry; Michael K Racke; Anthony T Reder; John Rose; Dean M Wingerchuk; Allan J MacKenzie-Graham; Douglas L Arnold; Chi Hong Tseng; Robert Elashoff
Journal:  Lancet Neurol       Date:  2015-11-29       Impact factor: 44.182

Review 4.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

5.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

6.  Treatment of multiple sclerosis with the pregnancy hormone estriol.

Authors:  Nancy L Sicotte; Stephanie M Liva; Rochelle Klutch; Paul Pfeiffer; Seth Bouvier; Sylvia Odesa; T C Jackson Wu; Rhonda R Voskuhl
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

7.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.

Authors:  S Vukusic; I Ionescu; M El-Etr; M Schumacher; E E Baulieu; C Cornu; C Confavreux
Journal:  J Neurol Sci       Date:  2009-09-15       Impact factor: 3.181

8.  The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.

Authors:  Rashad Hussain; Abdel M Ghoumari; Bartosz Bielecki; Jérôme Steibel; Nelly Boehm; Philippe Liere; Wendy B Macklin; Narender Kumar; René Habert; Sakina Mhaouty-Kodja; François Tronche; Regine Sitruk-Ware; Michael Schumacher; M Said Ghandour
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

9.  Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Authors:  Florian Kurth; Eileen Luders; Nancy L Sicotte; Christian Gaser; Barbara S Giesser; Ronald S Swerdloff; Michael J Montag; Rhonda R Voskuhl; Allan Mackenzie-Graham
Journal:  Neuroimage Clin       Date:  2014-03-06       Impact factor: 4.881

10.  Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.

Authors:  Roy Y Kim; Darian Mangu; Alexandria S Hoffman; Rojan Kavosh; Eunice Jung; Noriko Itoh; Rhonda Voskuhl
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
View more
  1 in total

Review 1.  Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair.

Authors:  Jocelyn M Breton; Kimberly L P Long; Matthew K Barraza; Olga S Perloff; Daniela Kaufer
Journal:  Biomolecules       Date:  2021-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.